Rare Disease and Orphan Products Breakthrough Summit Archives

TSC Preclinical Consortium: Facilitating Drug Development Through Collaboration of Patient Advocacy, Industry and Academia

by admin | Jul 6, 2017

ROBERDS L.S1, LEISER C.S2, GHAVAMI A3, KWAN M3, BELTRAN J3,2 SONG D2, DEVILBISS M.D2, WONG M4, RENSING N14, BRUNNER D1 1Tuberous Sclerosis Alliance, Silver Spring, MD, USA; 2Translational EEG, PsychoGenics, Tarrytown, NY, USA; 3PsychoGenics, Montvale, NJ, USA; 4Dept....

TSC Preclinical Consortium: Facilitating Drug Development Through Collaboration of Patient Advocacy, Industry and Academia

Recent Comments

CONTACT

Email: info@psychogenics.com

Phone: (914) 406-8019